Ridgeback Capital

Makers of change Investors in humanity

Dr Holman is the Founder and CEO of Ridgeback Capital, co-founder of Ridgeback Biotherapeutics, and serves as Co-Chair of the Ridgeback-Merck Molnupiravir Joint Steering Committee For over 20 years Dr Holman has provided funding to over 100 public and private biopharma companies to facilitate the research and development of transformational medicines to help people with unmet needs Dr Holman is a licensed physician and graduate of New York University School of Medicine and has an undergraduate degree in economics from Yale University He lives in Miami with his wife, 4 children, 3 dogs, and 1 bunny

Ridgeback Capital was founded in 2006 and is focused on healthcare investments Ridgeback invests in private and public companies that are dedicated to the development of life saving and life changing therapies Healthcare advances take many years to materialize and Dr Holman believes that patient capital is vital for new technologies and companies to thrive

More about the team

Ridgeback Capital is named after our founder’s Rhodesian Ridgeback Coco Coco was rescued from an animal shelter For, over a decade, she happily thrived and was proud to be the namesake of Ridgeback Capital Somewhat analogous to building a great company, Coco’s story is an excellent reminder that all good outcomes require thoughtful people who make great decisions

Ridgeback news and press releases

Wayne Holman and Wendy Holman, founder of Ridgeback Biotherapeutics created a pill to transform Covid-19 treatment by significantly lessening symptoms 12 20 2021 348 West 14th Street, New York, NY, 10014 Philosophy Investments About Contact